冷大气等离子体抗高级别胶质瘤的研究综述
该综述总结了冷大气等离子体(CAP)在神经肿瘤领域的应用研究,涵盖体外与临床前研究,并简要提及正在进行的CAP癌症治疗临床试验。CAP可通过等离子体射流直接或经等离子体活化物质间接给药,诱导活性氧氮介导的细胞死亡、增强抗肿瘤免疫或提高肿瘤对系统治疗的敏感性。CAP已在包括胶质瘤在内的多种癌症中显示选择性细胞死亡且对周围正常组织副作用极小。
要点
- CAP通过活性氧氮介导的细胞死亡、免疫调节等机制发挥抗胶质瘤作用。
- CAP可经等离子体射流直接或经等离子体活化介质/生物凝胶间接给药。
- CAP在多种癌症中显示选择性杀伤肿瘤细胞且对正常组织副作用小。
核心结论
- CAP在神经肿瘤领域展现治疗潜力,体外与临床前研究支持其抗高级别胶质瘤活性,相关临床试验正在开展。
研究设计与样本
- 综述总结了截至发表时CAP在神经肿瘤应用的体外与临床前研究,并简要提及正在进行的CAP癌症治疗临床试验。
主要发现
- CAP可诱导RONS介导的细胞死亡机制直接杀伤癌细胞。
- CAP可增强抗肿瘤免疫或提高肿瘤对系统治疗的敏感性。
- CAP还可通过紫外线照射、热效应和电磁效应诱导细胞坏死。
- CAP在皮肤、乳腺、结直肠、头颈及胶质瘤等多种癌症中引起选择性细胞死亡,对周围正常组织副作用极小。
临床怎么用
- CAP可作为高级别胶质瘤的潜在局部治疗手段,直接经等离子体射流或间接经等离子体活化物质给药。
局限性
- 证据主要来自体外与临床前研究,临床疗效与安全性尚待临床试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cold atmospheric plasma (CAP), a partially ionized near-room temperature gas (argon or helium), generates a variety of oxygen and nitrogen reactive species which can have a multitude of downstream biological effects including cell death, inflammation, and immune modulation. CAP is therefore a powerful tool with many potential medical applications, particularly in cancer treatment. As primary treatment, CAP can be administered directly through a plasma jet, or indirectly via plasma activated substances (i.e. media, biogels, etc.). CAP has been shown to directly kill cancer cells by inducing RONS-mediated cell death mechanisms, enhance anti-tumor immunity or increase the tumor's responsiveness to systemic therapies. While the chemical factors (i.e. RONS-mediated apoptosis) is the most studied mechanism of CAP efficacy, CAP can also induce necrosis of cells through ultraviolet irradiation, thermal and electromagnetic effects, which tend to lead to necrosis. CAP has been shown to cause selective cell death in various cancers, including skin, breast, colorectal, head and neck, and more recently in gliomas, with minimal side effects to surrounding normal tissues. CONCLUSION: We summarize the studies investigating CAP applications in neuro-oncology to date, including in vitro and pre-clinical studies, followed by a brief mention of ongoing clinical trials for CAP as a cancer treatment.
引用
- Peeters S, Kim WJ, Armellini A, et al. The activity of cold atmospheric plasma against high-grade glioma: a review. J Neurooncol. 2025. PMID: 41160270. doi:10.1007/s11060-025-05290-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。